Question 1

What is the catalog number for Gliadin (43-49) (Gliadorphin) Alpha Peptide?

Accepted Answer

The catalog number for Gliadin (43-49) (Gliadorphin) Alpha Peptide is PE-88514.

Question 2

What sizes are available for Gliadin (43-49) (Gliadorphin) Alpha Peptide?

Accepted Answer

Gliadin (43-49) (Gliadorphin) Alpha Peptide is available in the following size(s): 1 mg, 5 mg, 10 mg.

Question 3

How many pack sizes does Gliadin (43-49) (Gliadorphin) Alpha Peptide come in?

Accepted Answer

Gliadin (43-49) (Gliadorphin) Alpha Peptide is available in 3 different pack sizes.

Question 4

Is Gliadin (43-49) (Gliadorphin) Alpha Peptide in stock?

Accepted Answer

Gliadin (43-49) (Gliadorphin) Alpha Peptide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 6

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 7

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

Gliadin (43-49) (Gliadorphin) Alpha Peptide

Product Specifications

Type

Available Sizes

Frequently Asked Questions

Explore Other Products

Anti-CD40L/Cd40lg Antibody Picoband® (Cy3 Conjugate)

TLR7 Recombinant Rabbit Monoclonal Antibody [JA93-11]

Anti-VEGF/VEGFA Antibody Picoband®, FITC Conjugate

Vimentin (Mesenchymal Cell Marker) (VIM/1937R), CF405S conjugate, 0.1mg/mL

Anti-HBZ Antibody Picoband®

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), 1mg/mL